PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT OR 5-AMINOLEVULINIC ACID
    1.
    发明申请
    PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT OR 5-AMINOLEVULINIC ACID 有权
    光敏性治疗使用光敏剂或5-氨基酸

    公开(公告)号:US20140128799A1

    公开(公告)日:2014-05-08

    申请号:US14126929

    申请日:2012-06-20

    IPC分类号: A61N5/06 A61K41/00

    摘要: It is to provide photodynamic therapy (PDT) and photodynamic diagnosis (PDD) which are suitable for the diagnosis and therapy of a part requiring a certain degree of deep penetration, such as subcutaneous cancer and lymph nodes surrounded by blood vessels and fat. This is solved by performing PDT and PDD targeting cancer by administering a composition comprising a photosensitizing agent such as a tetrapyrrole-based compound (photofrin, protoporphyrin IX, etc.) or ALAs such as 5-aminolevulinic acid (ALA), ALA methyl ester, ALA ethyl ester, ALA propyl ester, ALA butyl ester, ALA pentyl ester, or a hydrochloride, phosphate, or sulfate thereof followed by irradiation with excitation light at a wavelength of 480 to 580 nm.

    摘要翻译: 它是提供光动力疗法(PDT)和光动力学诊断(PDD),适用于诊断和治疗需要一定程度深度穿透的部位,如皮下癌和由血管和脂肪包围的淋巴结。 通过施用包含光敏剂如四吡咯基化合物(光调节素,原卟啉IX等)或ALA的组合物,例如5-氨基乙酰丙酸(ALA),ALA甲酯, ALA乙酯,ALA丙酯,ALA丁酯,ALA戊酯或其盐酸盐,磷酸盐或硫酸盐,然后用波长480〜580nm的激发光照射。